Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | HMGCR | P04035 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18035640 | 0.91 | ALOX5 (0.44) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL15914612 | 0.89 | ALOX5 (0.50) | TYRALOX5TRPV1 | |
| SCHEMBL874193 | 0.89 | TYR (0.40) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL26046430 | 0.85 | TYR (0.40) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL31152022 | 0.83 | SMPD1 (0.41) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL25322106 | 0.79 | TYR (0.46) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL873591 | 0.79 | CA1 (0.40) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL26046434 | 0.78 | TYR (0.44) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL28544350 | 0.78 | TYR (0.44) | TYRALOX5CA1CA2GABRA1 | |
| SCHEMBL358256 | 0.76 | TYR (0.43) | TYRALOX5CA1CA2GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3061448-B1 | COMPOSITION CONTAINING EUGENOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ATOPIC DERMATITIS | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2020-07-29 | — | — | EP | disclosed |
| US-20160256421-A1 | COMPOSITION CONTAINING EUGENOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ATOPIC DERMATITIS | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2016-09-08 | — | — | US | disclosed |
| EP-3061448-A1 | COMPOSITION CONTAINING EUGENOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ATOPIC DERMATITIS | Seoul National University R&DB Foundation (KR) | 2016-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160256421-A1 | COMPOSITION CONTAINING EUGENOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ATOPIC DERMATITIS | EBP, TSLP, EED | TYR 7/4885ALOX5 352/4885CA1 4602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.